NINDS Neuroscience Funding Announcements

The National Institute of Neurological Disorders and Stroke (NINDS) is considering issuing a contract for preclinical studies of new or improved pharmaceutical preparations to be used as medical countermeasures against chemical agents that could be used in a terrorist attack. As a first step, the Institute is attempting to identify expert sources to conduct safety, pharmacokinetic/biodistribution, and developmental chemistry studies with candidate drugs.